Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Reverse Transcriptase Polymerase Chain Reaction × Clear all

NCT01270880 2018-09-18

Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Phase 2 Completed

18 enrolled 8 charts

Prostatic Neoplasms

NCT01338792 2014-03-10

Oxaliplatin and Pemetrexed Disodium in Treating Patients With Refractory Hormone-Resistant Prostate Cancer

Phase 2 Completed

47 enrolled 10 charts

Prostatic Neoplasms